Essential Tremor
-
Press Releases
Encora Therapeutics Receives FDA 510(k) Clearance for Encora X1™, a Breakthrough Wearable Device for Essential Tremor
–Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Encora X1™. “We started Encora with a simple goal: to restore independence for movement disorder patients. Today, we are one step closer to making that vision a reality.” Alli Davanzo, co-founder and vice president, Encora TherapeuticsShare…
Read More » -
Press Releases
Fasikl Receives FDA Clearance for Felix NeuroAI Wristband, the First and Only AI-Powered Treatment for Essential Tremor
Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic medicine and artificial intelligence (AI), today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the first-of-its-kind Felix™ NeuroAI™ Wristband for tremor-related functional limitations in the upper limbs in adults with essential tremor. “The Felix wristband represents a significant step forward in noninvasive, personalized…
Read More »